Rheumatoid Arthritis Completed Phase 3 Trials for Abatacept (DB01281)

Also known as: RA / Rheumatic Arthritis / Arthritis, Rheumatoid / Arthritis,Rheumatoid / Rheumatoid Arthritis (RA) / Rheumatoid Arthritis(RA) / Arthritis, Rheumatoid (RA) / Systemic rheumatoid arthritis / Arthritis rheumatoid / Rheumatoid arthritis, unspecified / R arthritis / Rh arthritis / Atrophic arthritis

IndicationStatusPhase
DBCOND0027961 (Rheumatoid Arthritis)Completed3
clinicaltrials.gov IdentifierTitlePurposeDrugs
NCT00547521Phase IIIB Subcutaneous Abatacept Monotherapy StudyTreatment
NCT00559585Methotrexate-Inadequate Response StudyTreatment
NCT00663702Phase IIIB Switching From Intravenous to Subcutaneous StudyTreatment
NCT00048568A Phase III Study of Abatacept (BMS-188667) in Patients With Active Rheumatoid Arthritis and Inadequate Response to MethotrexateTreatment
NCT00048932A Phase III Study of BMS-188667 in Subjects With Active Rheumatoid ArthritisTreatment
NCT00048581Phase III Study of BMS-188667 (CTLA4Ig) in Patients With Rheumatoid Arthritis Who Are Currently Failing Anti-TNF Therapy or Who Have Failed Anti-TNF Therapy in the Past.Treatment
NCT00095147Abatacept and Infliximab in Combination With Methotrexate in Subjects With Rheumatoid ArthritisTreatment
NCT00122382Remission and Joint Damage Progression in Early Rheumatoid ArthritisTreatment
NCT00124982Study of Abatacept (BMS-188667) in Subjects With Active Rheumatoid Arthritis on Background Non-biologic DMARDS (Disease Modifying Antirheumatic Drugs) Who Have an Inadequate Response to Anti-TNF TherapyTreatment
NCT00533897Phase IIIB Subcutaneous Missed Dose StudyTreatment
NCT00929864Abatacept Versus Adalimumab Head-to-HeadTreatment
NCT01844895Methotrexate-Inadequate Response Autoinjector Device Sub StudyTreatment
NCT00484289A Phase III Study of Abatacept in Japanese Subjects With Rheumatoid ArthritisTreatment
NCT01299961Ultrasound Scores as Indication of Response to Subcutaneous Abatacept in Subjects With Rheumatoid Arthritis
NCT00409838A Phase III Study of Abatacept in Patients With Rheumatoid Arthritis and an Inadequate Response to MethotrexateTreatment
NCT00989235Substudy - Low Dose of Abatacept in Subjects With Rheumatoid ArthritisTreatment
NCT01142726Efficacy and Safety Study of Abatacept Subcutaneous Plus Methotrexate in Inducing Remission in Adults With Very Early Rheumatoid ArthritisTreatment
NCT00767325A Rheumatoid Arthritis Study to Assess Early Response to Abatacept+MTX as Defined by Improvement of Synovitis Measures by Power Doppler UltrasonographyPrevention
NCT01350804Efficacy at 24 Weeks and Safety, Tolerability and Long Term Efficacy of Secukinumab (AIN457) in Patients With Active Rheumatoid Arthritis (RA) and an Inadequate Response to Anti-Tumor Necrosis Factor α (Anti-TNFα) Agents (CAIN457F2309 and CAIN457F2309E1)Treatment
NCT01351480Benefits of Injectable Abatacept Using Magnetic Resonance Imaging (MRI) in Rheumatoid Arthritis (RA) PatientsTreatment